BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34969746)

  • 1. The Clinical Desire for Pressurized Intraperitoneal Aerosol Chemotherapy in South Korea: An Electronic Survey-based Study.
    Lee EJ; Park SJ; Lee J; Mun J; Paik H; Seol A; Kim J; Yim GW; Shim SH; Kim HS; Chang SJ;
    Anticancer Res; 2022 Jan; 42(1):363-371. PubMed ID: 34969746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
    Odendahl K; Solass W; Demtröder C; Giger-Pabst U; Zieren J; Tempfer C; Reymond MA
    Eur J Surg Oncol; 2015 Oct; 41(10):1379-85. PubMed ID: 26138283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
    Nowacki M; Alyami M; Villeneuve L; Mercier F; Hubner M; Willaert W; Ceelen W; Reymond M; Pezet D; Arvieux C; Khomyakov V; Lay L; Gianni S; Zegarski W; Bakrin N; Glehen O
    Eur J Surg Oncol; 2018 Jul; 44(7):991-996. PubMed ID: 29526367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: a systematic review including evidence from Japan.
    Kitai T
    Surg Today; 2021 Jul; 51(7):1085-1098. PubMed ID: 33185798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis.
    Larbre V; Alyami M; Mercier F; Vantard N; Bonnefoy I; Opsomer MA; Villeneuve L; Bakrin N; Rioufol C; Glehen O; Kepenekian V
    Anticancer Res; 2018 Dec; 38(12):6869-6875. PubMed ID: 30504403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis.
    Demtröder C; Solass W; Zieren J; Strumberg D; Giger-Pabst U; Reymond MA
    Colorectal Dis; 2016 Apr; 18(4):364-71. PubMed ID: 26400556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressurized Intraperitoneal Aerosol Chemotherapy, a Palliative Treatment Approach for Patients With Peritoneal Carcinomatosis: Description of Method and Systematic Review of Literature.
    Winkler CS; Sandhu J; Pettke E; Merchea A; Fong Y; Kumara HMCS; Whelan RL
    Dis Colon Rectum; 2020 Feb; 63(2):242-255. PubMed ID: 31914116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.
    Loungnarath R; Causeret S; Bossard N; Faheez M; Sayag-Beaujard AC; Brigand C; Gilly F; Glehen O
    Dis Colon Rectum; 2005 Jul; 48(7):1372-9. PubMed ID: 15909071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience.
    Tempfer CB; Celik I; Solass W; Buerkle B; Pabst UG; Zieren J; Strumberg D; Reymond MA
    Gynecol Oncol; 2014 Feb; 132(2):307-11. PubMed ID: 24275155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study.
    Sgarbura O; Hübner M; Alyami M; Eveno C; Gagnière J; Pache B; Pocard M; Bakrin N; Quénet F
    Eur J Surg Oncol; 2019 Dec; 45(12):2386-2391. PubMed ID: 31092362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of patient reported outcomes (PROs) and quality of life measures after pressurized intraperitoneal aerosol chemotherapy (PIPAC).
    Taibi A; Geyl S; Salle H; Salle L; Mathonnet M; Usseglio J; Durand Fontanier S
    Surg Oncol; 2020 Dec; 35():97-105. PubMed ID: 32862112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
    Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
    Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasis.
    Javanbakht M; Mashayekhi A; Branagan-Harris M; Horvath P; Königsrainer A; Reymond MA; Yaghoubi M
    Eur J Surg Oncol; 2022 Jan; 48(1):188-196. PubMed ID: 34479745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)", the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology.
    Dueckelmann AM; Fink D; Harter P; Heinzelmann V; Marth C; Mueller M; Reinthaller A; Tamussino K; Wimberger P; Sehouli J
    Arch Gynecol Obstet; 2018 Apr; 297(4):837-846. PubMed ID: 29356953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review.
    Ploug M; Graversen M; Pfeiffer P; Mortensen MB
    BMC Cancer; 2020 Feb; 20(1):105. PubMed ID: 32041558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressurized Intraperitoneal Aerosol Chemotherapy-Related Clinical Trials in the Treatment of Peritoneal Metastases.
    Ukegjini K; Putora PM; Guidi M; Süveg K; Cihoric N; Widmann B; Steffen T
    Oncology; 2021; 99(9):601-610. PubMed ID: 34265774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
    Robella M; Vaira M; De Simone M
    World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis.
    Tempfer CB; Giger-Pabst U; Seebacher V; Petersen M; Dogan A; Rezniczek GA
    Gynecol Oncol; 2018 Jul; 150(1):23-30. PubMed ID: 29743140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis.
    Alyami M; Gagniere J; Sgarbura O; Cabelguenne D; Villeneuve L; Pezet D; Quenet F; Glehen O; Bakrin N; Passot G
    Eur J Surg Oncol; 2017 Nov; 43(11):2178-2183. PubMed ID: 28964609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study.
    Tempfer CB; Rezniczek GA; Ende P; Solass W; Reymond MA
    Anticancer Res; 2015 Dec; 35(12):6723-9. PubMed ID: 26637888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.